Precision BioSciences, Inc. (DTIL) Financials

DTIL Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 143.9 million 67.8 million
Dec. 31, 2025 154.4 million 62.2 million
Sept. 30, 2025 93.5 million 76.9 million
June 30, 2025 108.9 million 74.9 million

DTIL Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -12.0 million 1.5 million
Dec. 31, 2025 -11.3 million 2.0 million
Sept. 30, 2025 -15.3 million 2.4 million
June 30, 2025 -20.3 million 2.9 million

DTIL Net Income

No data available :(

DTIL Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 101.2 million 22.4 million 4.5 million
Dec. 31, 2025 115.6 million 22.4 million 6.4 million
Sept. 30, 2025 44.9 million 22.4 million 5.3 million
June 30, 2025 62.2 million 22.4 million 7.1 million

DTIL Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 12.8 million
Dec. 31, 2025 12.8 million
Sept. 30, 2025 11.8 million
June 30, 2025 11.0 million

DTIL Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 18000 13.1 million 6.8 million -
Dec. 31, 2025 34000 14.5 million 7.2 million -
Sept. 30, 2025 15000 13.4 million 7.3 million -
June 30, 2025 2000 12.4 million 9.1 million -

DTIL Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 10.8 million -
Dec. 31, 2025 34.2 million 678000
Sept. 30, 2025 13000 674000
June 30, 2025 18000 696000

DTIL Revenue by Segment
Graph available only for paid members. Upgrade to see it.

DTIL

Price: $6.50

52 week price:
3.53
8.82

Earnings Per Share: -2.17 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 459600

Market Capitalization: 77.5 million

Links: